About Kyle

This author has not yet filled in any details.
So far Kyle has created 187 blog entries.

CEO Roundtable on Cancer Names William Louv Chief Executive Officer, Elects Amgen’s R&D Leader David Reese, Major General Elder Granger Directors

2022-06-14T00:00:00-05:00June 14, 2022|

The CEO Roundtable on Cancer (CEORT) Board of Directors today announced that William C. Louv, PhD, will lead the organization as Chief Executive Officer effective immediately, and it has elected two new Directors: David M. Reese, MD, Executive Vice President of R&D at Amgen, and Major General Elder Granger, MD, President and CEO of THE 5Ps, LLC.

New consensus disease definitions to aid care, accelerate research for cancer patients with side effects from immunotherapies

2021-07-28T00:00:00-05:00July 28, 2021|

A paper outlining consensus disease definitions for neurological toxicities in cancer patients undergoing immune checkpoint inhibitor treatment was published this week in the Journal for ImmunoTherapy of Cancer (JITC) by a team of physicians at 16 institutions. Neurologists and oncologists at Massachusetts General Hospital with support from scientists at Project Data Sphere® led the team to deliver the first consensus-based definitions of disease and severity criteria for any immune-related toxicity. 

Go to Top